We are upgrading our infrastructure for a faster experience. We appreciate your patience in the meantime.
A pharmaceutical intermediate is a compound formed at a defined step in the chemical synthesis of an Active Pharmaceutical Ingredient (API). While not pharmacologically active on its own, it is essential to the multi-step pathway that leads to the final API. These intermediates can be early-stage or late-stage, and their regulatory handling depends on their proximity to the […]
Pharmaceutical Intermediate Read More »
What is the Pharmaceutical Supply Chain? The Pharma Supply Chain is the network of interconnected stages and stakeholders involved in sourcing raw materials ( APIs, excipients, intermediates), manufacturing finished drug products, packaging, distribution, and delivering medicines safely to healthcare providers, pharmacies, hospitals, and ultimately patients. Why Does the Pharma Supply Chain Matter? Ensures quality, safety, and efficacy of medicines throughout the journey. Helps
Pharmaceutical Supply Chain Read More »
What is Pharmacopeial Compliance? Pharmacopeial Compliance is the practice by which pharmaceutical manufacturers, suppliers, and distributors ensure their materials, drug substances, drug products, and excipients conform to the standards (monographs, test methods, acceptance criteria) published in one or more official pharmacopeias, such as: USP‑NF, European Pharmacopoeia, Indian Pharmacopoeia, Japanese Pharmacopeia, etc.. Compliance includes keeping up with current versions, performing
Pharmacopeial Compliance Read More »
What is PEP? PEP, or Post-Exposure Prophylaxis, refers to a short-term regimen of medication – most commonly antiretroviral therapy, administered after possible exposure to HIV to reduce the risk of infection. It must be initiated within 72 hours, with earlier administration being more effective. Why is PEP Critical in HIV Prevention? HIV can establish infection rapidly, often within 24
Post-Exposure Prophylaxis (PEP) Read More »
What is Post-Market Surveillance (PMS)? Post-Market Surveillance (PMS) refers to the continuous monitoring and evaluation of pharmaceutical products, medical devices, or APIs after they have been released into the market. It involves systematically collecting, analyzing, and interpreting data on product performance, adverse effects, and safety signals to ensure ongoing compliance with Good Pharmacovigilance Practices (GVP) and regulatory standards. PMS is a
Post-Market Surveillance (PMS) Read More »
What is a Product Specification Sheet in Pharma? A Product Specification Sheet is a detailed document that defines all essential attributes, requirements, and acceptance criteria for a pharmaceutical product (or its components, e.g., API, excipient, finished dosage form). It includes test parameters, materials, performance, safety, regulatory compliance, and packaging details. It serves as the benchmark for quality and consistency.
Product Specification Sheets Read More »
